期刊文献+

妊娠期糖尿病与血糖正常孕妇胰岛素抵抗及胰岛β细胞功能比较 被引量:11

The comparison of insulin resistance and pancreatic β-cell function in normal pregnant women and gestational diabetes mellitus
下载PDF
导出
摘要 目的对比观察妊娠期糖尿病(GDM)与血糖正常孕妇胰岛素抵抗及胰岛β细胞功能。方法选择187例有GDM危险因素的产妇进行前瞻性研究,于早孕期和中孕期进行口服葡萄糖耐量试验(OGTT)检查,根据OGTT结果分为GDM组(86例)和非GDM组(对照组,101例)。检测两组胰岛素水平,采用稳态模型评估胰岛素抵抗指数(HOMA-IR)、胰岛β细胞功能指数(HOMA-β),计算早期胰岛素分泌指数(ΔI30/ΔG30)、混合胰岛素敏感度(ISIcomp)并比较。结果 GDM组早孕期、中孕期的HOMA-IR显著高于对照组,ΔI30/ΔG30、ISIcomp显著低于对照组。与早孕期相比,中孕期对照组和GDM组的HOMA-IR显著高于早孕期,ΔI30/ΔG30、ISIcomp显著低于早孕期。结论 GDM患者早孕期就存在明显的胰岛素抵抗。应进行严格管理,控制血糖,保护胰岛β细胞功能,从而改善妊娠结局。 Objective To compare of insulin resistance and pancreaticβ-cell function in normal pregnant women and gestational diabe-tes mellitus. Methods 187 cases of pregnant women with risk factors for GDM was collected in prospective study. OGTT was conducted in early and middle pregnancy and insulin level was detected. Homeostasis model assessment for insulin resistance index( HOMA-IR)and pancreaticβ-cell function index( HOMA-β)was calculated. Early insulin secretion index(ΔI30/ΔG30 ),mixed insulin sensitivity( ISIcomp)were calcu-lated and compared between the two groups. Results In the GDM group,we found 86 cases in control group,we found 101 cases in pregnant women. In early and middle pregnancy in GDM group,HOMA-IR was significantly higher,ΔI30/ΔG30 ,ISIcomp significantly lower than the con-trol group. Compared with early pregnancy,HOMA-IR in GDM group and the control group in middle pregnancy was significantly higher than that of early pregnancy.ΔI30/ΔG30 ,ISIcomp was significantly lower than that of early pregnancy. Conclusion In pregnant women with gestational diabetes during early pregnancy,there is a significant insulin resistance. We should strictly manage and control fasting glucose,protect isletβ-cell function,and thereby improving pregnancy outcomes.
出处 《临床和实验医学杂志》 2014年第24期2066-2068,共3页 Journal of Clinical and Experimental Medicine
关键词 妊娠期糖尿病 胰岛素抵抗 胰岛Β细胞 Gestational diabetes Insulin resistance Pancreatic β cells
  • 相关文献

参考文献8

  • 1Kim C.Gestational diabetes mellitus in korean women;similarities and differences from other racial/ethnic groups [J].Diabetes Metab J,2014,38(1):1-12.
  • 2Magon N,Seshiah V.Gestational diabetes mellitus:insulinic manage- ment [J].J Obstet Gynaecol India,2014,64(2):82-90.
  • 3Barrett HL,Dekker Nitert M,Conwell LS,et al.Probiotics for preven- ting gestational diabetes [J].Cochrane Database Syst Rev,2014,2:CD009951.
  • 4International Association of Diabetes and Pregnancy Study Groups Con- sensus Panel.International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hypergly- cemia in pregnancy[J].Diabetes Care,2010,33(3):676-682.
  • 5Lacroix M,Kina E,Hivert MF.Maternal/fetal determinants of insulin resistance in women during pregnancy and in offspring over life [J].Curr Diab Rep,2013,13(2):238-44.
  • 6Harlev A,Wiznitzer A.New insights on glucose pathophysiology in ges- tational diabetes and insulin resistance [J].Curr Diab Rep,2010,10(3):242-247.
  • 7张宗凤,王慎金.妊娠期糖尿病患者肿瘤坏死因子与胰岛素抵抗的相关性研究[J].现代医药卫生,2012,28(12):1807-1807. 被引量:5
  • 8Lambrinoudaki I,Vlachou SA,Creatsas G.Genetics in gestational dia- betes mellitus:association with incidence,severity,pregnancy outcome and response to treatment[J].Curr Diabetes Rev,2010,6(6):393-399.

二级参考文献11

同被引文献92

  • 1苏日娜,杨慧霞.美国糖尿病学会2013年妊娠期糖尿病诊治标准[J].中国医学前沿杂志(电子版),2013,5(5):7-8. 被引量:35
  • 2刘丽华,于桂梅,石芳鑫.胰岛素抵抗在妊娠期糖尿病发病机制中的作用[J].中国妇幼保健,2005,20(11):1375-1377. 被引量:13
  • 3吕维名,许荣,肖丽霞,高晓梅.甲状腺功能亢进症患者的胰岛素抵抗及胰岛B细胞功能状态——附28例分析[J].新医学,2007,38(7):444-446. 被引量:5
  • 4Kim C. Gestational diabetes me|litus in korean women: similarities and differences from other racial/ethnic groups[ J]. Diabetes Metab J,2014, 38(1) :1 -12.
  • 5Magon N, Seshiah V. C, estational diabetes mellitus: insulinic manage- ment[J]. J Obstet Gynaecol India, 2014,64(2) :82 -90.
  • 6Korkmazer E, Solak N. Correlation between inflammatory markers and insulin resistance in pregnancy[ J]. J Obstet Gynaecol, 2014,11:1 -4.
  • 7Virzt GM, Clementi A, de Cal M, et al. Genomics and biological ac- tivity of neutrophil gelatinase - associated lipocalin in several clinical settings[ J]. Blood Purif,2013,35 ( 1 - 3 ) : 139 - 143.
  • 8Zhu RT, Gong JP. The role of neutrophil gelatinase - associated lipoca- lin (NGAL) in the glycolipid metabolism and inflammation[ J]. Sheng Li Ke Xue Jin Zhan,2012,43(3) :198 -201.
  • 9Ragab D, Abdallah DM, E1 - Abhar HS. Cilostazol renoprotective effect : modulation of PPAR - , NGAL, KIM - 1 and IL - 18 underlies its novel effect in a model of ischemia - reperfusion [ J ]. PLoS One, 2014,9(5) :e95313.
  • 10Moreno - Navurrcte JM, Manco M, Ib6? ez J, et al. Metabolic endo- toxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance [ J ]. Int J Obes ( Lond), 2010,34 (2) :240 -249.

引证文献11

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部